文献速递艾滋病与性传播感染结核与非结核分枝杆菌

HIV感染儿童抗逆转录病毒治疗后病原体特异性免疫重建差异

Differential Pathogen-Specific Immune Reconstitution in Antiretroviral Therapy-Treated Human Immunodeficiency Virus-Infected Children.
PubMed 文献 · J Infect Dis · 2019-01-01

该前瞻性研究纳入25例HIV感染儿童,在ART启动前和1年后检测HIV、CMV和TB特异性T细胞应答。发现1年ART后CD4 T细胞细胞因子谱呈病原体特异性差异变化,伴记忆表型转变和PD-1表达下降。CMV和TB特异性应答恢复与PD-1下降相关(r=0.83,P=.008;r=0.81,P=.0007)。

要点

  • ART1年后HIV、TB、CMV特异性免疫重建模式不同
  • CMV和TB特异性应答恢复与PD-1表达下降相关
  • PD-1通路可能是免疫重建不良者的免疫治疗靶点

核心结论

  • ART后免疫重建伴随T细胞表型、功能和PD-1表达的alterations,且HIV、TB和CMV各具特点。
  • PD-1通路是ART后免疫重建不足的HIV感染者的潜在免疫治疗靶点。

研究设计与样本

  • 前瞻性队列研究,纳入25例HIV感染儿童。
  • 在ART启动前和启动1年后,用细胞内细胞因子染色检测HIV、CMV和TB特异性T细胞应答。
  • 同时检测活化、免疫耗竭和记忆表型标志物,以及抗原刺激后的增殖应答。

主要发现

  • ART1年后CD4 T细胞应答的细胞因子谱呈病原体特异性差异变化,伴记忆表型转变和PD-1表达下降。
  • ART1年后HIV和PPD特异性应答的增殖能力增加。
  • CMV特异性应答恢复与PD-1下降相关(r=0.83,P=.008)。
  • TB特异性应答恢复与PD-1下降相关(r=0.81,P=.0007)。

临床怎么用

  • 对ART后免疫重建不足的HIV感染儿童,可关注PD-1通路作为潜在免疫干预靶点。
  • 评估免疫重建时需考虑HIV、TB、CMV特异性应答的差异,不宜一概而论。

局限性

  • 样本量25例,研究结论需更大样本验证。
  • 仅观察ART后1年,缺乏更长随访数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Susceptibility to coinfections in human immunodeficiency virus (HIV)-infected patients remains increased despite antiretroviral therapy (ART). To elucidate mechanisms involved in immune reconstitution, we studied immune activation, immune exhaustion, and HIV- and copathogen-specific T-cell responses in children before and after ART. METHODS: We prospectively enrolled 25 HIV-infected children to study HIV-, cytomegalovirus (CMV)-, and tuberculosis (TB)-specific T-cell responses before and 1 year after initiation of ART using intracellular cytokine (interleukin-2, interferon-γ, tumor necrosis factor-α) staining assays after in vitro stimulation. We further measured expression of activation, immune exhaustion, and memory phenotype markers and studied proliferative responses after antigen stimulation. RESULTS: We observed differential, pathogen-specific changes after 1 year of ART in cytokine profiles of CD4 T-cell responses that were associated with shifts in memory phenotype and decreased programmed cell death 1 (PD-1) expression. The proliferative capacity of HIV- and PPD-specific responses increased after 1 year of ART. Of note, the recovery of CMV- and TB-specific responses was correlated with a decrease in PD-1 expression (r = 0.83, P = .008 and r = 0.81, P = .0007, respectively). CONCLUSIONS: Reconstitution of immune responses on ART is associated with alterations in T-cell phenotype, function, and PD-1 expression that are distinct for HIV, TB, and CMV. The PD-1 pathway represents a potential target for immunotherapy in HIV-infected patients on ART with insufficient immune reconstitution.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Muenchhoff M, Adland E, Roider J, et al. Differential Pathogen-Specific Immune Reconstitution in Antiretroviral Therapy-Treated Human Immunodeficiency Virus-Infected Children. J Infect Dis. 2019. PMID: 30624717. doi:10.1093/infdis/jiy668

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。